← Return to Testosterone: Is everyone's level in the low numbers?

Discussion

Testosterone: Is everyone's level in the low numbers?

Prostate Cancer | Last Active: Sep 25 8:27am | Replies (44)
Comment receiving replies
@northoftheborder

There is a phase II trial underway now for using Apalutamide (Erleada) and Cetrelimab (Libtayo) together to treat neuroendocrine cancer, following on results of earlier, smaller studies. Unfortunately, the trial is no longer accepting new participants, and even if it does turn out to be successful, it will probably be a few years before it's generally available as a treatment.
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2021-05986

Jump to this post

Replies to "There is a phase II trial underway now for using Apalutamide (Erleada) and Cetrelimab (Libtayo) together..."
jeffmarc | @jeffmarc | Sep 23 9:47pm

Someone I know is getting a scan to see if qualifies for the neuroendocrine study at UC Davis. At first his hemoglobin was below eight so he wasn’t eligible, but he’s gotten it up with blood transfusions so he’s now getting the scan.

Not sure if this is the same study you’re talking about, but they are taking patients for this one.

VIEW AND REPLY